Industry: Medical Devices & Consumables
Published Date: 2026-03-05
Pages: 111 Pages
Report ld: 6012099
Request Sample
Customized Report
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size(US$)

CAGR 2026-2032
11.3%
Market Size,2032
USD 3,603
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market was valued at US$ 1721 million in 2025 and is anticipated to reach US$ 3603 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Micro Invasive Glaucoma Surgery (MIGS) Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Glaucoma is a disease characterized by optic disc atrophy and depression, visual field loss, and decreased vision. Impaired aqueous humor circulation in the eye causes elevated intraocular pressure (IOP), exceeding the optic nerve's tolerance, leading to chronic optic nerve damage. With the aging population, the number of glaucoma patients is increasing annually.
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.Therefore, it has attracted considerable attention in the glaucoma treatment field and holds promising clinical application prospects. It has become a popular market segment for many ophthalmic medical device companies.
The market for minimally invasive glaucoma surgery (MIGS) devices is experiencing rapid growth. This growth is primarily driven by the clinical needs of 80 million glaucoma patients worldwide, an aging population, and increased healthcare coverage. Currently, the market is dominated by trabecular meshwork drainage devices (such as the iStent), accounting for 38% of the market share, but subconjunctival drainage (XEN Gel Stent) and suprachoroidal drainage (Hydrus) technologies are rapidly gaining market share. North America holds nearly 60% of the global market, followed closely by Europe. The Asia-Pacific region (particularly China) holds significant potential due to localized production and expanding healthcare coverage. In the competitive landscape, leading companies such as Glaukos, Alcon, and AbbVie are consolidating their advantages through technological innovations (such as AI-guided navigation and biodegradable stents), while emerging companies are focusing on differentiated indications and cost optimization. Future trends include expanding indications for early intervention, combination use with cataract surgery (expected to account for over 70% of the market share), and accelerated localized production in emerging markets.
This report delivers a comprehensive overview of the global Micro Invasive Glaucoma Surgery (MIGS) Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Micro Invasive Glaucoma Surgery (MIGS) Devices. The Micro Invasive Glaucoma Surgery (MIGS) Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Micro Invasive Glaucoma Surgery (MIGS) Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Micro Invasive Glaucoma Surgery (MIGS) Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Micro Invasive Glaucoma Surgery (MIGS) Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Micro Invasive Glaucoma Surgery (MIGS) Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Overview
1.1 Product Definition
1.2 Micro Invasive Glaucoma Surgery (MIGS) Devices by Type
1.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Value by Type: 2025 vs 2032
1.2.2 MIGS Stents
1.2.3 MIGS Shunts
1.2.4 Others
1.3 Micro Invasive Glaucoma Surgery (MIGS) Devices by Application
1.3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Ophthalmology Clinics
1.3.4 Others
1.4 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size Estimates and Forecasts
1.4.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue 2021–2032
1.4.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales 2021–2032
1.4.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Competition by Manufacturers
2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Micro Invasive Glaucoma Surgery (MIGS) Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Micro Invasive Glaucoma Surgery (MIGS) Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Micro Invasive Glaucoma Surgery (MIGS) Devices, Product Types and Applications
2.7 Global Key Manufacturers of Micro Invasive Glaucoma Surgery (MIGS) Devices, Date of Entry into the Industry
2.8 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Situation and Trends
2.8.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Players Market Share by Revenue
2.8.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scenario by Region
3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2021–2032
3.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2021–2026
3.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region: 2027–2032
3.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2021–2032
3.3.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2021–2026
3.3.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region: 2027–2032
3.4 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.4.1 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2021–2032)
3.4.3 North America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.5.1 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2021–2032)
3.5.3 Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.7.1 Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2021–2032)
3.7.3 Latin America Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2021–2032)
4.1.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2021–2026)
4.1.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Type (2027–2032)
4.1.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Type (2021–2032)
4.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2021–2032)
4.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2021–2026)
4.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Type (2027–2032)
4.2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Type (2021–2032)
4.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2021–2032)
5.1.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2021–2026)
5.1.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales by Application (2027–2032)
5.1.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Market Share by Application (2021–2032)
5.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2021–2032)
5.2.1 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2021–2026)
5.2.2 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue by Application (2027–2032)
5.2.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Revenue Market Share by Application (2021–2032)
5.3 Global Micro Invasive Glaucoma Surgery (MIGS) Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Glaukos Corporation
6.1.1 Glaukos Corporation Company Information
6.1.2 Glaukos Corporation Description and Business Overview
6.1.3 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Glaukos Corporation Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.1.5 Glaukos Corporation Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Company Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Alcon Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AbbVie Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 iSTAR Medical
6.4.1 iSTAR Medical Company Information
6.4.2 iSTAR Medical Description and Business Overview
6.4.3 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 iSTAR Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.4.5 iSTAR Medical Recent Developments/Updates
6.5 New World Medical
6.5.1 New World Medical Company Information
6.5.2 New World Medical Description and Business Overview
6.5.3 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 New World Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.5.5 New World Medical Recent Developments/Updates
6.6 Nova Eye Medical
6.6.1 Nova Eye Medical Company Information
6.6.2 Nova Eye Medical Description and Business Overview
6.6.3 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nova Eye Medical Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.6.5 Nova Eye Medical Recent Developments/Updates
6.7 Sight Sciences
6.7.1 Sight Sciences Company Information
6.7.2 Sight Sciences Description and Business Overview
6.7.3 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sight Sciences Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.7.5 Sight Sciences Recent Developments/Updates
6.8 HealthGuard Biomed
6.8.1 HealthGuard Biomed Company Information
6.8.2 HealthGuard Biomed Description and Business Overview
6.8.3 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 HealthGuard Biomed Micro Invasive Glaucoma Surgery (MIGS) Devices Product Portfolio
6.8.5 HealthGuard Biomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Industry Chain Analysis
7.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Production Mode & Process Analysis
7.4 Micro Invasive Glaucoma Surgery (MIGS) Devices Sales and Marketing
7.4.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Sales Channels
7.4.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Distributors
7.5 Micro Invasive Glaucoma Surgery (MIGS) Devices Customer Analysis
8 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
8.1 Micro Invasive Glaucoma Surgery (MIGS) Devices Industry Trends
8.2 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Drivers
8.3 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Challenges
8.4 Micro Invasive Glaucoma Surgery (MIGS) Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 137
USD 4900.00
(Single User License)
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1721 million in 2025 and is projected to reach US$ 3603 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1567 million in 2024 to US$ 3271 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 141
USD 4900.00
(Single User License)
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 92
USD 3950.00
(Single User License)
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 79
USD 4250.00
(Single User License)
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published Date: 2025-10-17
Pages: 85
USD 2900.00
(Single User License)
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 83
USD 3950.00
(Single User License)
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 94
USD 4350.00
(Single User License)
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published Date: 2024-07-17
Pages: 80
USD 3950.00
(Single User License)
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1721 million in 2025 to US$ 3603 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 137
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1721 million in 2025 and is forecast to reach a readjusted size of US$ 3603 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1721 million in 2025 and is projected to reach US$ 3603 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 108
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market is projected to grow from US$ 1567 million in 2024 to US$ 3271 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 141
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 92
The global Micro Invasive Glaucoma Surgery (MIGS) Devices market size was US$ 1567 million in 2024 and is forecast to a readjusted size of US$ 3271 million by 2031 with a CAGR of 11.3% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 79
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was valued at US$ 1567 million in the year 2024 and is projected to reach a revised size of US$ 3271 million by 2031, growing at a CAGR of 11.3% during the forecast period.
Published: 2025-10-17
Pages: 85
The global market for Micro Invasive Glaucoma Surgery (MIGS) Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 83
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 94
MIGS is a new surgical method that uses extremely small devices and very delicate operations to reduce intraocular pressure. Although traditional surgery can effectively reduce intraocular pressure, it brings more trauma and more postoperative complications. The difference is that MIGs can effectively reduce intraocular pressure and avoid complications, and can also be applied to patients whose glaucoma symptoms have not reached the advanced stage.
Published: 2024-07-17
Pages: 80
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now